Two diagnostic developments signaled momentum for scalable HIV monitoring. South Korea’s Bioneer secured EU IVDR Class D certification for its AccuPower HIV‑1 Quant Kit on an automated ExiStation FA 96 platform, positioning the firm for international procurement and Global Fund listing. Separately, Irish startup Altratech won a $441,437 Gates Foundation grant to optimize a point‑of‑care molecular viral‑load test that combines peptide nucleic acids, magnetic beads and a silicon chip to count virus‐linked beads—an approach intended to bring PCR‑sensitivity viral‑load testing to decentralized settings. Both moves aim to broaden access to quantitative HIV monitoring in low‑resource and clinical settings.